Sanofi's Genzyme rare diseases division already sells another enzyme replacement therapy for Pompe disease based on the recombinant enzyme alglucosidase alfa – sold as Myozyme in Europe and ...

Although Genzyme also produces Myozyme (alglucosidase alpha) at the plant, no runs were scheduled during the presumed period of shutdown so supplies of that drug will not be affected. With sales ...

The study of first generation rhGAA (myozyme), expressed in Chinese hamster ovary (CHO) cells, and next-generation glyco-engineered rhGAA, produced in yeast cells to finetune the mannose-6-phosphate ...